Postoperative parathormone level and permanent hypoparathyroidism following total thyroidectomy: a clue for the clinician.

AIM: Hypoparathyroidism (HPP) is among the most commonly observed severe complications of total thyroidectomy (TT). Therefore, any permanent hypoparathyroidism (PHPP) that may develop in the postoperative period must be predicted as early as possible. This study aims to investigate the predictive value of intact parathormone (iPTH) levels on the first postoperative day after TT for PHPP. MATERIALS AND METHODS: The study included 407 patients who underwent TT. Demographic information (sex and age), preoperative thyroid function, postoperative histopathological findings, the presence of a parathyroid gland on the pathology specimen and the length of hospital stay were recorded for all patients. iPTH and total serum calcium and albumin levels™ were measured on the first postoperative day. According to the postoperative day 1 iPTH level (above or below 12 pg/ml), the patients were divided into two groups and compared in terms of risk factors for postoperative HPP. Patients with HPP who had low iPTH and calcium levels at the end of a 6-month follow-up were considered to have PHPP. RESULTS: No significant differences were found between groups regarding demographic characteristics, preoperative diagnosis, type of operation and histopathological results (p > 0.05). The long-term follow-up of patients with HPP revealed PHPP in two patients and transient HPP in 98 patients. PHPP did not develop in patients with an iPTH level higher than 1 pg/ml on postoperative day 1. The mean time for patients to reach normal serum iPTH levels was 38.53 (± 58.22) days. CONCLUSION: iPTH levels higher than 1 pg/ml on the first postoperative day after TT may be a clinical indicator that PHPP will not develop in these patients. KEY WORDS: Calcium, Hypocalcaemia, Hypoparathyroidism, Total Thyroidectomy.

The Role of Ca 19-9, Ca 72-4, Cea and Cholesterol Levels in Predicting Malignancy in Gallbladder Polyps.

OBJECTIVE: To determine the association of malignancy potential of gallbladder polyps with tumor markers and cholesterol levels, and at which value the presence of malignancy should be suspected. STUDY DESIGN: Observational study. PLACE AND DURATION OF STUDY: University of Health Sciences, Adana City training and research Hospital from December 2017 to November 2020. METHODOLOGY: Ninety patients diagnosed with gallbladder polyp by abdominal ultrasonography, were included in the study. Patients were divided into subgroups of true pseudopolyp, cholesterol-non-cholesterolpolyp, malignant-non-malignant polyp. The groups were compared in terms of age, gender, polyp size, number of polyps, preoperative total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), triglyceride, Ca 19-9 (carbohydrate antigen 19-9), Ca 72-4 (carbohydrate antigen 72-4), Cea (carcinoembryonic antigen) levels. RESULTS: In the true polyp group, polyp size, Ca 19-9, Ca 72-4 and Cea median values were significantly higher (p=0.001, p=0.029, p=0.003, and p=0.007, respectively); whereas, triglyceride levels were significantly lower compared to the pseudopolyp group (p=0.002). Polyp size was significantly lower in cholesterol polyp group compared to non-cholesterol polyp group (p= 0.032), and LDL and triglyceride medians were significantly higher (p=0.031, and p<0.001) in cholesterol group. Among the true polyps, polyp size, Ca 19-9, Ca 72-4 and Cea levels were significantly higher in adenocarcinoma group than non-malignant polyp groups (p<0.05). Cut-off values were determined as >11 mm AUC: 0.906 for size, >24.1 U/mL. AUC: 1.00 for Ca 19-9, >9.6 U/mL AUC: 1.00 for Ca 72-4, and >40 ng/mL AUC: 0.984 for CEA, respectively. CONCLUSION: Polyps larger than 11mm with high levels of CEA, Ca 72-4, Ca 19-9, evaluated together, may act as a guide for the clinician in predicting malignancy. The availability of economical and accessible parameters may allow a new algorithm to be developed in the treatment and follow-up approach of gallbladder polyps. Key Words: Gallbladder polpys, Ca 19-9 antigen, Ca 72-4 antigen, Tumor marker, Gallbladder cancer.